Sep 07,2017

Fitbit, Dexcom team up to bring CGM data to Fitbit's new smartwatch

Good news for anyone who thought Fitbit's move toward the smartwatch market would be a move away from health: The wearable maker has just announced a partnership with Dexcom that will bring data from the company's continuous glucose monitor directly to the display of Fitbit's upcoming Ionic smartwatch.

COLLABORATION PARTNERSHIP

#connected device

#cgm

View Analyst & Ambassador Comments
Go to original news
Sep 13,2017

Livongo acquires Diabeto to expand options for members

Mountain View, California-based Livongo Health, the chronic condition management technology company founded by former Allscripts CEO Glen Tullman, has acquired Diabeto, a diabetes management company based in Piscataway, New Jersey in the US and Maharashtra in India. The terms of the acquisition were not disclosed. Diabeto makes a small device, shaped like a bird, that connects to more than 40 popular glucose meters and essentially turns them into Bluetooth-connected meters.

COLLABORATION MERGERS & ACQUISITION

#product & service

#bgm

#virtual care

View Analyst & Ambassador Comments
Go to original news
Sep 22,2017

New Dexcom API lets third-party apps access users' glucose data

Continuous glucose monitoring company Dexcom, which already allows users to monitor their CGM data on their phones and Apple Watch, is now making some patient data available to third parties via an API.

PRODUCT

#cgm

View Analyst & Ambassador Comments
Go to original news
Sep 25,2017

Sanofi, Aetna-Inova JV target diabetes with digital therapeutic pilot program

Sanofi and Innovation Health — an insurance company jointly run by Inova and Aetna —have announced a pilot program examining the impact of digital health strategies to improve care for Type 2 diabetes patients. The program will tap One Drop, a diabetes self-management app and Bluetooth blood sugar monitor, and Gocap of Common Sensing, a mobile-friendly device and insulin dose management platform that emphasizes physician involvement, in an effort to improve medication adherence and patient outcomes.

COLLABORATION PARTNERSHIP

#r&d

#insulin pen

#mobile app

View Analyst & Ambassador Comments
Go to original news
Sep 27,2017

Abbott's Freestyle Libre system becomes first CGM to be FDA cleared for use without fingersticks

Abbott Diabetes Care's Freestyle Libre Flash Glucose Monitoring System has been approved by the FDA.

REGULATORY FDA

#cgm

View Analyst & Ambassador Comments
Go to original news
Sep 28,2017

In small study, Noom’s mobile coaching platform shows promise in reducing hypertension

A mobile hypertension prevention program (HPP) delivered through Noom’s mobile health coaching service appears to significantly benefit users with consistently high blood pressure, according to a study conducted by the company and recently published in the Journal of Human Hypertension. Noom has already developed a behavior change platform designed to assist diabetes patients that appeared successful in clinical trials, and was the first fully mobile diabetes prevention program to be recognized by the CDC.

CLINICAL STUDY

#mobile app

#coaching

View Analyst & Ambassador Comments
Go to original news
Sep 01,2017

FDA selects participants for new digital health software precertification pilot program

Today, the U.S. Food and Drug Administration announced the names of the companies selected to participate in a first-of-its kind pilot program that will help revolutionize digital health regulation in the U.S. FDA Commissioner Scott Gottlieb, M.D. announced today the nine participants, including Tidepool, of the FDA’s digital health software precertification pilot program (FDA Pre-cert) during his keynote address at the AdvaMed MedTech Conference in San Jose, California.

View Analyst & Ambassador Comments
Go to original news
Sep 01,2017

Engagement and outcomes in a digital Diabetes Prevention Program: 3-year update

Translations of the Diabetes Prevention Program (DPP) have proliferated in recent years, with increasing expansion to digital formats. Although these DPP translations have consistently shown favorable clinical outcomes, long-term data for digital formats are limited. This study’s objective was to examine clinical outcomes up to 3 years post-baseline and the relationship between program engagement and clinical outcomes in a digital DPP.

CLINICAL STUDY
View Analyst & Ambassador Comments
Go to original news
Sep 05,2017

MetLife Hong Kong partners with Health2Sync to facilitate self-management for its diabetic policy holders

MetLife Hong Kong announced today that it has extended the scope of its "MetLife Health-is-Wealth Medical Plan" to include people living with diabetes, and offered its customers insurtech solutions for proactive health management. Using a combination of examination and data insights, consumers can benefit from bespoke premium rates and gain access to an online health self-management tool, Health2Sync.

COLLABORATION PARTNERSHIP

#insurance

#mobile app

View Analyst & Ambassador Comments
Go to original news
Sep 06,2017

Senseonics to Present at the Morgan Stanley 15th Annual Global Healthcare Conference

Senseonics Holdings Inc.(NYSE-MKT: SENS), a medical technology company focused on the development and commercialization of Eversense®, today announced the company plans to participate in the Morgan Stanley 15th Annual Global Healthcare Conference in New York, NY. Senseonics’ management is scheduled to present on Monday, September 11, 2017 at 1:40 PM ET.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES